|
|
|
Insider
Information: |
Brennan Daniel J. |
Relationship: |
Director |
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
272,248 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$20,358,775 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
272,248 |
|
|
Total
Value |
$20,358,775 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
8.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
EVP and CFO |
2024-02-20 |
271,542 |
|
0 |
Premium* |
|
Nuance Communications Inc |
NUAN |
Director |
2022-03-04 |
0 |
2018-09-10 |
0 |
Premium* |
|
Waters Corp |
WAT |
Director |
2024-01-02 |
706 |
2022-11-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2016-02-27 |
4 |
D |
$17.21 |
$20,979 |
D/D |
(1,219) |
150,398 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2014-02-27 |
4 |
D |
$13.30 |
$21,586 |
D/D |
(1,623) |
91,171 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2015-02-16 |
4 |
D |
$14.98 |
$21,841 |
D/D |
(1,458) |
108,910 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2014-02-16 |
4 |
D |
$13.30 |
$22,131 |
D/D |
(1,664) |
71,310 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2014-02-28 |
4 |
D |
$13.10 |
$23,501 |
D/D |
(1,794) |
94,877 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2015-02-27 |
4 |
D |
$16.90 |
$27,361 |
D/D |
(1,619) |
129,935 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2016-02-23 |
4 |
D |
$17.24 |
$30,067 |
D/D |
(1,744) |
162,445 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2015-02-28 |
4 |
D |
$16.90 |
$30,217 |
D/D |
(1,788) |
133,646 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2015-02-24 |
4 |
D |
$16.62 |
$30,980 |
D/D |
(1,864) |
126,577 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2016-02-28 |
4 |
D |
$17.21 |
$44,591 |
D/D |
(2,591) |
153,305 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2016-02-24 |
4 |
D |
$17.33 |
$46,808 |
D/D |
(2,701) |
252,240 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-15 |
4 |
D |
$44.01 |
$53,648 |
D/D |
(1,219) |
275,313 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-02-15 |
4 |
OE |
$0.00 |
$55,957 |
D/D |
11,725 |
285,107 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-02-15 |
4 |
D |
$47.29 |
$57,647 |
D/D |
(1,219) |
283,888 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-02-16 |
4 |
D |
$46.48 |
$58,100 |
D/D |
(1,250) |
279,309 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-02-18 |
4 |
D |
$37.52 |
$61,683 |
D/D |
(1,644) |
277,091 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-02-21 |
4 |
D |
$38.03 |
$61,761 |
D/D |
(1,624) |
279,128 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2016-02-25 |
4 |
AS |
$17.48 |
$63,278 |
D/D |
(3,620) |
149,029 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2018-02-23 |
4 |
D |
$27.20 |
$64,872 |
D/D |
(2,385) |
272,007 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2018-02-22 |
4 |
D |
$26.48 |
$68,186 |
D/D |
(2,575) |
269,027 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-21 |
4 |
D |
$42.55 |
$69,101 |
D/D |
(1,624) |
272,826 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2018-02-24 |
4 |
D |
$27.20 |
$69,333 |
D/D |
(2,549) |
275,192 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-18 |
4 |
D |
$42.55 |
$69,952 |
D/D |
(1,644) |
270,789 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-02-15 |
4 |
D |
$38.39 |
$70,714 |
D/D |
(1,842) |
275,029 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2020-02-21 |
4 |
D |
$42.62 |
$70,749 |
D/D |
(1,660) |
254,697 |
0 |
- |
|
169 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|